Cue Biopharma Reports Q2 Financials, Misses EPS but Beats Revenue

Cue Biopharma announced its latest financial results, with GAAP EPS of -$24.14 missing estimates by $22.23, while revenue of $7.88M surpassed expectations by $5.78M.